News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SciGen Ltd (SIE.AX) Buys China Rights to Generex Biotechnology Corporation (GNBT) Oral Insulin Spray


4/14/2008 12:19:22 PM

April 14, 2008 -- SciGen, Ltd. (ASX: SIE), a Singapore company that trades in Australia, has licensed the China rights to Oral-lyn™, an oral insulin spray product that is being developed by Generex (NSDQ: GNBT). SciGen will supply its own recombinant human insulin product, while Generex will formulate and fill Generex Oral-lyn for marketing and distribution by SciGen in the Asia-Pacific region. More details...

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES